The Trump administration’s dramatic reworking of U.S. public-health agencies’ approach to vaccines is creating a difficult and unpredictable situation for drugmakers. Pfizer, in particular, could be ...
In response to a call from President Donald Trump to make the positive impact of Covid-19 vaccines public, drug giant Pfizer posted a collection of more than 200 news releases and statements and 27 ...
Sept 3 (Reuters) - Pfizer (PFE.N), opens new tab and Moderna (MRNA.O), opens new tab on Wednesday defended their COVID-19 vaccines as having saved millions of lives worldwide, in separate responses to ...
Matthew Herper covers medical innovation — both its promise and its perils. Pfizer CEO Albert Bourla on Wednesday defended the development of Covid vaccinations, including Pfizer’s own, suggesting ...
WASHINGTON – President Donald Trump said Sept. 1 he is now demanding that COVID-19 vaccine manufacturers prove that their shots have been effective, adding to his long string of comments alternately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results